Related Experiment Videos
Pharmacotherapy of depression in children
J T Wilson1, R C Parish, A del Mundo
1LSU Medical Center, Department of Pediatrics, Shreveport 71130-3932, USA.
Insights
Depression significantly impacts children
Area of Science:
- Child and Adolescent Psychiatry
- Neuroscience
- Pharmacology
Background:
- Childhood depression affects cognitive and social development.
- Antidepressant use in pediatric populations is increasing.
- Selective serotonin reuptuptake inhibitors (SSRIs) show promise but lack established safety and efficacy data in children.
Purpose of the Study:
- To review the current understanding of depression in children and adolescents.
- To examine the design of studies evaluating newer antidepressant treatments for pediatric depression.
- To highlight the need for established safety and efficacy data for SSRIs in this age group.
Main Methods:
- Literature review of studies on pediatric depression.
- Analysis of research methodologies for antidepressant trials in children.
- Synthesis of existing data on SSRI use in adolescents and children.
Main Results:
- Depression poses significant risks to children's development.
- Limited established safety and efficacy data exist for newer antidepressants in pediatric populations.
- Current study designs may require refinement for pediatric populations.
Conclusions:
- Further rigorous research is essential to establish the safety and efficacy of selective serotonin reuptake inhibitors for treating depression in children and adolescents.
- Improved study designs are needed to accurately assess treatment outcomes in pediatric populations.
- Addressing the growing use of antidepressants requires robust evidence-based guidelines.
Abstract:
Depression can interfere with the overall functioning of children and adolescents. It can impair normal cognitive and social development. The use of antidepressant medications in children and adolescents has grown in the past decade. Newer antidepressant agents, the selective serotonin reuptake inhibitors, appear very promising, but their safety and efficacy have not been established for children. This review focuses on depression and the design of studies for its treatment with newer antidepressant drugs in children.